Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sculptor Capital Investments is an investment entity associated with the alternative asset management business formerly known as Och-Ziff and later rebranded as Sculptor Capital. Available public records indicate that the requested name does not correspond to a life sciences, biotech, pharma, or healthcare operating company, but rather to an investment-related legal entity. The entity appears to have existed under the Och-Ziff name and later as Sculptor Capital Investments, with ties to the broader Sculptor Capital Management organization. Sculptor Capital Management itself was acquired by Rithm Capital in 2023. As a result, this is best classified as a non-healthcare investment company rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziff Capital Investments.